Clinical Genetics · Galveston, TX
NPI
1083960884
Since 2012
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
301 University Blvd, Research Building 6, Suite 3.350
Galveston, TX, 77555
Phone (409) 772-3466
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,987
46 services
Medicare patients, 2023
11
Average age 52
Drug cost, 2024
$1.8M
66 prescriptions
Company payments, 2025
$190K
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Joseph W Ray prescribed most often to Medicare patients was Palynziq (Pegvaliase-Pqpz), with 26 prescriptions and refills. In total Joseph W Ray wrote 66 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Palynziq Pegvaliase-Pqpz | 26 | 26 | Under 11 | $1.2M |
| Fabrazyme Agalsidase Beta | 25 | 25 | Under 11 | $346K |
Brand drugs: 56 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph W Ray $190K ($190K in general payments such as food, travel and fees) from 11 companies. The largest payer was Genzyme Corporation with $106K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 74 | $106K |
| Mirum Pharmaceuticals, Inc. MIRM | 59 | $55K |
| BioMarin Pharmaceutical Inc. BMRN | 27 | $26K |
| ITF Therapeutics LLC | 2 | $2,650 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $209 |
| PTC Therapeutics, Inc. PTCT | 1 | $175 |
| Sarepta Therapeutics, Inc. SRPT | 4 | $172 |
| Ultragenyx Pharmaceutical Inc. RARE | 2 | $76.06 |
| Cycle Pharmaceuticals Inc | 1 | $26.27 |
| Sanofi US Services Inc. SNY | 1 | $21.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.